Zobrazeno 1 - 10
of 82
pro vyhledávání: '"High-risk MDS"'
Autor:
Razan Mohty, Rama Al Hamed, Ali Bazarbachi, Eolia Brissot, Arnon Nagler, Amer Zeidan, Mohamad Mohty
Publikováno v:
Journal of Hematology & Oncology, Vol 15, Iss 1, Pp 1-16 (2022)
Abstract Myelodysplastic syndromes (MDS) are a heterogeneous clonal disease of myeloid neoplasms characterized by ineffective hematopoiesis, variable degree of cytopenias, and an increased risk of progression to acute myeloid leukemia (AML). Molecula
Externí odkaz:
https://doaj.org/article/12dfeeb36de342abb9dc383635ac2ca2
Autor:
Katherine Linder, Premal Lulla
Publikováno v:
Human Vaccines & Immunotherapeutics, Vol 17, Iss 8, Pp 2602-2616 (2021)
Patients with Myelodysplastic syndromes (MDS) have few therapy options for sustainable responses in the frontline setting, and even less after hypomethylating agent (HMA) failure in relapsed and refractory setting. The only potential cure is an allog
Externí odkaz:
https://doaj.org/article/25fec727a489408a845652c46e6dc7de
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Markus G. Manz, Harm Sinnige, Marie-Christiane Vekemans, Jürgen Kuball, Yves Chalandon, Dominik Heim, Lidwine W. Tick, Thomas Pabst, Peter E. Westerweel, Marjolein van der Poel, Dimitri Breems, Jeroen Janssen, Marie-Cecile Legdeur, Ine Moors, Carlos Graux, Rolf E. Brouwer, Wim Terpstra, Danielle van Lammeren-Venema, Dries Deeren, Johan Maertens, Okke de Weerdt, Peter A. von dem Borne, Marinus van Marwijk Kooy, Marten R. Nijziel, Arjan A. van de Loosdrecht, Mojca Jongen-Lavrencic, Mels Hoogendoorn, Florence Van Obbergh, Yvette van Norden, Anna Efthymiou, Bjørn-Tore Gjertsen, Georg Stussi, Gert J. Ossenkoppele, Margriet Oosterveld, Bart J. Biemond, Asiong Jie, Mario Bargetzi, Edo Vellenga, Marjolein van der Klift, Aurélie Jaspers, Saskia K. Klein, Olivier Spertini, Walter J.F.M. van der Velden, Urs Hess, Bob Löwenberg, Michael Gregor
Publikováno v:
Cancers, vol. 13, no. 4, pp. 672
Cancers, Vol. 13, No 4 (2021) P. 672
Cancers
Volume 13
Issue 4
Cancers, 13
Janssen, J, Löwenberg, B, Manz, M, Bargetzi, M, Biemond, B, von dem Borne, P, Breems, D, Brouwer, R, Chalandon, Y, Deeren, D, Efthymiou, A, Gjertsen, B T, Graux, C, Gregor, M, Heim, D, Hess, U, Hoogendoorn, M, Jaspers, A, Jie, A, Jongen-Lavrencic, M, Klein, S, van der Klift, M, Kuball, J, van Lammeren-Venema, D, Legdeur, M C, van de Loosdrecht, A, Maertens, J, Kooy, M V M, Moors, I, Nijziel, M, van Obbergh, F, Oosterveld, M, Pabst, T, van der Poel, M, Sinnige, H, Spertini, O, Terpstra, W, Tick, L, van der Velden, W, Vekemans, M C, Vellenga, E, de Weerdt, O, Westerweel, P, Stüssi, G, van Norden, Y & Ossenkoppele, G 2021, ' Inferior outcome of addition of the aminopeptidase inhibitor tosedostat to standard intensive treatment for elderly patients with aml and high risk mds ', Cancers, vol. 13, no. 4, 672, pp. 1-11 . https://doi.org/10.3390/cancers13040672
Cancers, Vol. 13, no. 4, p. 672 [1-11] (2021)
Cancers, Vol 13, Iss 672, p 672 (2021)
Cancers, 13(4):672, 1-11. Multidisciplinary Digital Publishing Institute (MDPI)
Janssen, Jeroen; Löwenberg, Bob; Manz, Markus; Bargetzi, Mario; Biemond, Bart; Borne, Peter von dem; Breems, Dimitri; Brouwer, Rolf; Chalandon, Yves; Deeren, Dries; Efthymiou, Anna; Gjertsen, Bjørn-Tore; Graux, Carlos; Gregor, Michael; Heim, Dominik; Hess, Urs; Hoogendoorn, Mels; Jaspers, Aurelie; Jie, Asiong; Jongen-Lavrencic, Mojca; ... (2021). Inferior Outcome of Addition of the Aminopeptidase Inhibitor Tosedostat to Standard Intensive Treatment for Elderly Patients with AML and High Risk MDS. Cancers, 13(4) MDPI AG 10.3390/cancers13040672
Cancers, 13, 4
Cancers, 13(4):672. Multidisciplinary Digital Publishing Institute (MDPI)
Cancers, 13(4):672. MDPI AG
CANCERS
Cancers, Vol. 13, No 4 (2021) P. 672
Cancers
Volume 13
Issue 4
Cancers, 13
Janssen, J, Löwenberg, B, Manz, M, Bargetzi, M, Biemond, B, von dem Borne, P, Breems, D, Brouwer, R, Chalandon, Y, Deeren, D, Efthymiou, A, Gjertsen, B T, Graux, C, Gregor, M, Heim, D, Hess, U, Hoogendoorn, M, Jaspers, A, Jie, A, Jongen-Lavrencic, M, Klein, S, van der Klift, M, Kuball, J, van Lammeren-Venema, D, Legdeur, M C, van de Loosdrecht, A, Maertens, J, Kooy, M V M, Moors, I, Nijziel, M, van Obbergh, F, Oosterveld, M, Pabst, T, van der Poel, M, Sinnige, H, Spertini, O, Terpstra, W, Tick, L, van der Velden, W, Vekemans, M C, Vellenga, E, de Weerdt, O, Westerweel, P, Stüssi, G, van Norden, Y & Ossenkoppele, G 2021, ' Inferior outcome of addition of the aminopeptidase inhibitor tosedostat to standard intensive treatment for elderly patients with aml and high risk mds ', Cancers, vol. 13, no. 4, 672, pp. 1-11 . https://doi.org/10.3390/cancers13040672
Cancers, Vol. 13, no. 4, p. 672 [1-11] (2021)
Cancers, Vol 13, Iss 672, p 672 (2021)
Cancers, 13(4):672, 1-11. Multidisciplinary Digital Publishing Institute (MDPI)
Janssen, Jeroen; Löwenberg, Bob; Manz, Markus; Bargetzi, Mario; Biemond, Bart; Borne, Peter von dem; Breems, Dimitri; Brouwer, Rolf; Chalandon, Yves; Deeren, Dries; Efthymiou, Anna; Gjertsen, Bjørn-Tore; Graux, Carlos; Gregor, Michael; Heim, Dominik; Hess, Urs; Hoogendoorn, Mels; Jaspers, Aurelie; Jie, Asiong; Jongen-Lavrencic, Mojca; ... (2021). Inferior Outcome of Addition of the Aminopeptidase Inhibitor Tosedostat to Standard Intensive Treatment for Elderly Patients with AML and High Risk MDS. Cancers, 13(4) MDPI AG 10.3390/cancers13040672
Cancers, 13, 4
Cancers, 13(4):672. Multidisciplinary Digital Publishing Institute (MDPI)
Cancers, 13(4):672. MDPI AG
CANCERS
Simple Summary Treatment results of acute myeloid leukemia (AML) in elderly patients are unsatisfactory. We investigated in an open label randomized phase II study whether addition of tosedostat, an aminopeptidase inhibitor, to intensive chemotherapy
Autor:
Romain Guieze, Jacques Delaunay, Sorin Visanica, Céline Berthon, Esperanza Such, Joan Bargay, Sophie Park, Pierre Fenaux, Stéphane de Botton, S.M. Rojas, Raphael Itzykson, Shanti Ame, J. Muñoz, Teresa Cedena, Elisa Luño, Lorenzo Ji, Celia Salanoubat, Guillermo Sanz, Joan Pérez Guallar, Norbert Vey, María Díez-Campelo, Odile Beyne-Rauzy, Llorenç Badiella, Jaime Pérez-Oteyza, Jesús M. Hernández-Rivas, Félix López-Cadenas, Dominique Bordessoule, Aspasia Stamatoullas, Emmanuel Gyan, Consuelo del Cañizo, Françoise Isnard
Publikováno v:
British Journal of Haematology
British Journal of Haematology, Wiley, 2018, 181 (3), pp.350-359. ⟨10.1111/bjh.15190⟩
BRITISH JOURNAL OF HAEMATOLOGY
r-IIS La Fe. Repositorio Institucional de Producción Científica del Instituto de Investigación Sanitaria La Fe
instname
British Journal of Haematology, Wiley, 2018, 181 (3), pp.350-359. ⟨10.1111/bjh.15190⟩
BRITISH JOURNAL OF HAEMATOLOGY
r-IIS La Fe. Repositorio Institucional de Producción Científica del Instituto de Investigación Sanitaria La Fe
instname
Treatment with azacitidine (AZA) has been suggested to be of benefit for higher-risk myelodysplastic syndrome (HR-MDS) patients with chromosome 7 abnormalities (Abn 7). This retrospective study of 235 HR-MDS patients with Abn 7 treated with AZA (n =
Autor:
Alessandro Sanna, Serena Pillozzi, Erico Masala, Valeria Santini, Ana Valencia-Martinez, Persio Dello Sbarba, Tommaso Rondelli, Annarosa Arcangeli, Alice Brogi, Antonella Gozzini
Publikováno v:
Oncotarget
Myelodysplastic Syndromes (MDS) are clonal neoplasms where stem/progenitor cells endowed with self-renewal and capable of perpetuating the disease have been demonstrated. It is known that oxygen tension plays a key role in driving normal hematopoiesi
Publikováno v:
Mediterranean Journal of Hematology and Infectious Diseases, Vol 2, Iss 2, Pp e2010012-e2010012 (2010)
No Abstract Available
Externí odkaz:
https://doaj.org/article/f1cb7a7f281343c084a85982502151b6
Publikováno v:
Mediterranean Journal of Hematology and Infectious Diseases, Vol 2, Iss 2, Pp e2010012-e2010012 (2010)
No Abstract Available
Externí odkaz:
https://doaj.org/article/3cab1ee636f943f9b8e4735a4b2a3a86
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.